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Background
Immune suppression is one of the hallmarks by which
head and neck squamous cell carcinoma (HNSCC)
develops a tumor permissible environment[1]. Sema-
phorin 4D (Sema4D), known for its various develop-
mental, physiological and pathological effects, was
recently shown to play a role in regulating the immune
system[2]. Sema4D is expressed in many epithelial
tumors including HNSCC[3]; yet, the effect of Sema4D
on modulating the inflammatory profile within the
tumor microenvironment of HNSCC remains to be
elucidated.
Methods
Human HNSCC cell lines HN6 and HN13 were used to
study the effect of Sema4D produced in tumor condi-
tioned media (TCM), on myeloid and T cells separated
from human peripheral blood mononuclear cells
(PBMC) of healthy donors. Neutralizing anti-Sema4D
antibody and Sema4D immune depletion from the TCM
were carried out. Lentivirus shRNA was also used to
knock down Sema4D in HNSCC-HN6 cells.
Results
Treatment of PBMC with TCM from HNSCC HN6 and
HN13 cell lines resulted in a significant induction in
myeloid derived suppressor cells (MDSC; CD33+ CD11b+
HLA-DR-/low) from freshly isolated CD33+ cells. This
increase in MDSC corresponded with the suppression of
autologous T cell proliferation and a reduction in IFN-g
production. Blockade of Sema4D in the TCM of HN6
and HN13 using anti-Sema4D antibody resulted in a sig-
nificant reduction in the MDSC population. Furthermore,
TCM from HN6 Sema4D-shRNA rescued the MDSC-
mediated T cell suppression and recovered IFN-g, com-
pared to the control. Analysis of the recovered T cell
population showed an increase in the effector T cell
population (CD4+Tbet+ and CD8+Tbet+), and a decrease
in regulatory T cells (CD4+CD25+FoxP3+). Mechanisti-
cally, we found a decrease in arginase-1 produced by
myeloid cells cultured in HN6 Sema4D-shRNA TCM, as
well as a reduction in the immune suppressive cytokines,
TGF-b, and IL-10.
Conclusion
This study describes a novel immunosuppressive
mechanism for HNSCC through Sema4D induction of
MDSCs. Collectively; our work highlights the therapeutic
potential of Sema4D inhibition as a strategy to improve
the efficacy of immunotherapy in HNSCC.
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